{"symbol":"BMY","fiscalQuarter":"Q1-2013","reportDate":"2013-04-25","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q1-2013","postBrief":{"headline":"Bristol Myers Squibb Misses on EPS, Stock Down 2.97%","keyNumbers":[{"metric":"EPS","actual":"$0.41","expected":"N/A","surprise":"-0.73%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management did not provide specific guidance for the upcoming quarters.","The company is focusing on maintaining its current portfolio amid market challenges."],"summary":"Management expressed caution regarding future performance without offering specific guidance. They emphasized a focus on their existing product lineup."},"guidanceChanges":{"summary":"No guidance data was available for this quarter.","changes":[]},"whatItMeans":"Bristol Myers Squibb's earnings report indicates a slight miss on EPS, which contributed to a 2.97% drop in stock price. The lack of revenue data and forward guidance may have raised concerns among investors about the company's near-term performance. The defensive tone from management suggests they are navigating challenges without clear expectations for improvement.","metaDescription":"Bristol Myers Squibb (BMY) Q1 2013 earnings: EPS missed expectations. Stock down 2.97%. Full breakdown."}}